Results 91 to 100 of about 1,044,094 (254)
NDARC webinar series presentation. A dangerous misnomer: 'synthetic cannabis'.
, 2021 The term ‘synthetic cannabis’ has been widely used to cover a diverse group of cannabinoid receptor agonists. In this presentation we discuss the characteristics of these drugs, and present the case that the term is a dangerous misnomer that has negative
Banister, Samuel, Darke, Shane
core
Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users [PDF]
, 2018 Objective: There is growing evidence regarding the numerous adverse effects of synthetic cannabinoids (SCBs) on the cardiovascular system; however, no studies have shown the cardiovascular effects of opioids using strain echocardiography.
Demirkiran, Aykut +3 more
core +1 more source
2273 Synthetic cannabinoid usage among psychiatric inpatients
Journal of Clinical and Translational Science, 2018 OBJECTIVES/SPECIFIC AIMS: Synthetic cannabinoids (SC) are widely available and are associated with acute psychosis. Our recent study indicated that SC using psychiatric inpatients admitted in 2014 had more psychotic symptoms, aggression, and agitation ...
Claire L. Mann +7 more
doaj +1 more source
Beyond abstinence: Redefining success in cannabis use disorder treatment
Addiction, EarlyView.Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin +3 more
wiley +1 more source
Addiction, EarlyView.Abstract Background and aims Use of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth.
Kathryn La Capria +10 more
wiley +1 more source
Case Reports in Psychiatry, 2016 Introduction. Marijuana has been used for its psychotropic effects including enhanced relaxation and perceptual alterations. However, the use of synthetic marijuana (SM) leads to more frequent and drastic side effects than the typical use of regular ...
John Samaan +5 more
doaj +1 more source
Addiction, EarlyView.Abstract Background and aims Over the past decade, there has been increased lifetime use of illicit and medical cannabis, underscoring the need to examine public health impacts. This includes reports of increased cannabis‐related psychosis. In this context, this study aimed to determine all cannabis‐related hospital admissions in Victoria, Australia ...
Myfanwy Graham +5 more
wiley +1 more source
AB-FUBINACA, A SYNTHETIC CANNABINOID IN “FUNKY GREEN STUFF™” [PDF]
, 2015 Objective: The objective of this research was to isolate and identify any potential synthetic cannabinoids disguised in the commercially available claimed-to-be herbal scent, known as “Funky Green Stuff™”.
Bojabarah, Haidar +3 more
core +1 more source
Synthetic cannabinoid induced acute respiratory depression: Case series and literature review
Respiratory Medicine Case Reports, 2017 Synthetic Cannabinoids are a street drug that is widely attainable and cheap compared to natural cannabis, and has variable potency and unpredictable effects with no commercially available diagnostic test to confirm its presence.
Mark Henry Alon +1 more
doaj +1 more source
Addiction, EarlyView.Abstract Background and aims Cannabis edible products are increasingly being sold on the illicit market around the world. Use of these products, typically labelled as containing Δ‐9‐tetrahydrocannabinol (THC), has been linked to adverse health effects, particularly amongst adolescents.
Matthew Gardner +9 more
wiley +1 more source